Compound ID | 492

Update compound information

DRG-16

Class: DNA synthesis inhibitor (pyrrolobenzodiazepine)

Spectrum of activity: Gram-negative
Details of activity: Double stranded DNA cross linking agent; part of the series of Spirogen pyrrolobenzodiazepines, this demonstrated strong anti-Gram positives activity
Institute where first reported: Spirogen Ltd (Medimmune, USA)
Year first mentioned: 2004
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 584.66
Iso. SMILES: COC1=C(C=C2C(=C1)C(=O)N3CC(=C)C[C@H]3C=N2)OCCCCCOC4=C(C=C5C(=C4)N=C[C@@H]6CC(=C)CN6C5=O)OC
InChI Key: KYNCKSRRIFFPJS-GOTSBHOMSA-N
Can. SMILES: C=C1C[C@H]2C=NC3=C(C=C(C(=C3)OCCCCCOC4=CC5=C(C=C4OC)C(=O)N6CC(=C)C[C@H]6C=N5)OC)C(=O)N2C1
InChI: InChI=1S/C33H36N4O6/c1-20-10-22-16-34-26-14-30(28(40-3)12-24(26)32(38)36(22)18-20)42-8-6-5-7-9-43-31-15-27-25(13-29(31)41-4)33(39)37-19-21(2)11-23(37)17-35-27/h12-17,22-23H,1-2,5-11,18-19H2,3-4H3/t22-,23-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9938287
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.